Analog Precision Medicine
← Back to Blog
Weight & Metabolism

Insulin Resistance vs. Type 2 Diabetes: The Spectrum Your Doctor May Not Explain

Dr. RP, MD — Board-Certified, Emergency Medicine & Critical Care Medicine — Founder, Analog Precision Medicine

In twenty years of emergency medicine, I've managed thousands of type 2 diabetes complications — DKA, hyperosmolar crises, infected foot ulcers, acute coronary syndromes with A1c levels of 11%. I know what the end of the metabolic spectrum looks like. But here's what struck me most: for the vast majority of those patients, the process started ten to twenty years before the diabetes diagnosis. It started with insulin resistance — a condition that doesn't have a billing code and rarely gets tested for.

The Iceberg

Insulin resistance means your cells respond less effectively to insulin, forcing your pancreas to produce more to maintain the same glucose level. Your fasting glucose is 92 — your doctor says you're fine. But your fasting insulin might be 18 (ideal is under 7–8) and your HOMA-IR might be 4.1 (ideal is under 1.5). That hyperinsulinemia drives visceral fat accumulation, chronic inflammation, endothelial dysfunction, and accelerated atherosclerosis.[1] The glucose is the tip. Everything below the waterline is doing the damage.

“By the time diabetes is diagnosed, studies suggest up to 50% of beta cell function is already lost.”

The Five Stages Nobody Explains

The progression runs from normal sensitivity through early insulin resistance (normal glucose, elevated insulin — invisible to standard labs), to prediabetes (compensation failing, glucose creeping up), to type 2 diabetes (fasting glucose above 126, A1c above 6.5%), to advanced complications. By the time diabetes is diagnosed, studies suggest up to 50% of beta cell function is already lost.[2]

Stages 2 and 3 are where intervention has the highest yield. But conventional medicine, relying on fasting glucose and A1c, is blind to stage 2 and often slow on stage 3.

Why Fasting Glucose Fails

Fasting glucose can remain normal for 5–10 years after insulin resistance begins. It measures the endpoint of a compensatory system — when it's elevated, the system has already failed.[3] A1c is better but can be affected by hemoglobin variants and masks glycemic variability.

The test that catches it early: fasting insulin, paired with glucose to calculate HOMA-IR (fasting insulin × fasting glucose / 405). Values above 2.0–2.5 suggest resistance. It's a $25 lab test that virtually nobody orders as screening.[4]

What Drives It and What Reverses It

Drivers: visceral adiposity (the strongest modifiable factor), sedentary behavior, sleep deprivation (one night of 4–5 hours reduces insulin sensitivity 25–30%), chronic inflammation, ultra-processed diets, and genetics.

The good news: stages 2 and 3 are largely reversible. Exercise is the single most powerful insulin sensitizer — resistance training and aerobic exercise both work, combination is best. Dietary modification (less refined carbs, more fiber, Mediterranean patterns), modest weight loss (5–10%), sleep optimization, and when appropriate, metformin or GLP-1 agonists.

Why This Matters

If you're between 30 and 65, not overweight, and your doctor says your glucose is normal — you might still have insulin resistance. The only way to know is fasting insulin. At Analog Precision Medicine, it's part of every baseline because catching this at stage 2 instead of stage 4 is the difference between a lifestyle intervention and a lifelong medication regimen.

References

  1. 1.DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis. Diabetologia. 2010;53(7):1270–1287.
  2. 2.UKPDS Group. Overview of 6 years' therapy of type 2 diabetes: a progressive disease. Diabetes. 1995;44(11):1249–1258.
  3. 3.Kraft JR. Detection of diabetes mellitus in situ (occult diabetes). Lab Med. 1975;6(2):10–22.
  4. 4.Matthews DR, et al. HOMA: insulin resistance from fasting glucose and insulin. Diabetologia. 1985;28:412–419.

Dr. RP, MD is dual board-certified in Emergency Medicine and Critical Care Medicine and is the founder of Analog Precision Medicine, a precision medicine practice in Southern California. This article is for educational purposes only and does not constitute medical advice or establish a physician-patient relationship.

← Back to Blog

Request Exploratory Call

We'll be in touch to schedule your introductory conversation.